ATE239750T1 - 6,11-verbrückte erythromycinderivate - Google Patents
6,11-verbrückte erythromycinderivateInfo
- Publication number
- ATE239750T1 ATE239750T1 AT98956314T AT98956314T ATE239750T1 AT E239750 T1 ATE239750 T1 AT E239750T1 AT 98956314 T AT98956314 T AT 98956314T AT 98956314 T AT98956314 T AT 98956314T AT E239750 T1 ATE239750 T1 AT E239750T1
- Authority
- AT
- Austria
- Prior art keywords
- erythromycin derivatives
- bridged erythromycin
- bridged
- derivatives
- erythromycin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96040097A | 1997-10-29 | 1997-10-29 | |
US15826998A | 1998-09-22 | 1998-09-22 | |
PCT/US1998/022941 WO1999021864A1 (en) | 1997-10-29 | 1998-10-29 | 6,11-bridged erythromycin derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE239750T1 true ATE239750T1 (de) | 2003-05-15 |
Family
ID=26854886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98956314T ATE239750T1 (de) | 1997-10-29 | 1998-10-29 | 6,11-verbrückte erythromycinderivate |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1027361B1 (de) |
JP (1) | JP2001521038A (de) |
KR (1) | KR20010031591A (de) |
CN (1) | CN1278266A (de) |
AR (1) | AR015986A1 (de) |
AT (1) | ATE239750T1 (de) |
AU (1) | AU1286799A (de) |
BG (1) | BG104425A (de) |
BR (1) | BR9813317A (de) |
CA (1) | CA2307828A1 (de) |
CO (1) | CO4990972A1 (de) |
DE (1) | DE69814441T2 (de) |
DK (1) | DK1027361T3 (de) |
ES (1) | ES2198766T3 (de) |
HU (1) | HUP0004323A2 (de) |
IL (1) | IL134996A0 (de) |
NO (1) | NO20002099L (de) |
PL (1) | PL340253A1 (de) |
PT (1) | PT1027361E (de) |
SK (1) | SK6342000A3 (de) |
TR (1) | TR200001140T2 (de) |
TW (1) | TW486485B (de) |
WO (1) | WO1999021864A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6437106B1 (en) * | 1999-06-24 | 2002-08-20 | Abbott Laboratories | Process for preparing 6-o-substituted erythromycin derivatives |
US6472372B1 (en) * | 2000-12-06 | 2002-10-29 | Ortho-Mcneil Pharmaceuticals, Inc. | 6-O-Carbamoyl ketolide antibacterials |
CN1589277A (zh) | 2001-09-17 | 2005-03-02 | 奥索-麦克尼尔药品公司 | 6-o-氨基甲酸酯-11,12-内酯-酮内酯抗菌剂 |
WO2003050132A1 (en) | 2001-12-05 | 2003-06-19 | Ortho-Mcneil Pharmaceutical, Inc. | 6-o-acyl ketolide derivatives of erythromycine useful as antibacterials |
US6753318B1 (en) | 2002-07-25 | 2004-06-22 | Enanta Pharmaceuticals, Inc. | 6,11-4-carbon bridged erythromycin derivatives |
CN1659178A (zh) | 2002-05-13 | 2005-08-24 | 英安塔制药有限公司 | 6、11二环红霉素衍生物 |
US7273853B2 (en) | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
US7910558B2 (en) * | 2002-05-13 | 2011-03-22 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
AU2003229037B8 (en) * | 2002-05-13 | 2009-07-02 | Enanta Pharmaceuticals, Inc. | 6,11 bicyclic erythromycin derivatives |
US6841664B2 (en) * | 2002-07-25 | 2005-01-11 | Enanra Pharmaceuticals, Inc. | 6,11-4-carbon bridged ketolides |
US6645941B1 (en) * | 2003-03-26 | 2003-11-11 | Enanta Pharmaceuticals, Inc. | 6,11-3C-bicyclic 9a-azalide derivatives |
WO2005067564A2 (en) | 2004-01-07 | 2005-07-28 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic erythromycin derivatives |
WO2005070113A2 (en) | 2004-01-09 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | 9n-substituted 6-11 bicyclic erythromycin derivatives |
WO2005080408A1 (en) * | 2004-01-23 | 2005-09-01 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
US7384921B2 (en) | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
US7384922B2 (en) | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
US7589067B2 (en) | 2005-10-12 | 2009-09-15 | Enanta Pharmaceuticals, Inc. | 6, 11-bridged tricyclic macrolides |
US8273720B2 (en) | 2007-09-17 | 2012-09-25 | Enanta Pharmaceuticals, Inc. | 6,11-bicyclolides: bridged biaryl macrolide derivatives |
US11673910B2 (en) | 2017-04-28 | 2023-06-13 | Zikani Therapeutics, Inc. | Macrolides with modified desosamine sugars and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0876388B1 (de) * | 1995-11-08 | 2004-02-18 | Abbott Laboratories | Tricyclische erythromycinderivate |
-
1998
- 1998-10-27 CO CO98062727A patent/CO4990972A1/es unknown
- 1998-10-27 AR ARP980105375A patent/AR015986A1/es unknown
- 1998-10-29 DE DE69814441T patent/DE69814441T2/de not_active Expired - Fee Related
- 1998-10-29 JP JP2000517973A patent/JP2001521038A/ja not_active Withdrawn
- 1998-10-29 PL PL98340253A patent/PL340253A1/xx unknown
- 1998-10-29 WO PCT/US1998/022941 patent/WO1999021864A1/en not_active Application Discontinuation
- 1998-10-29 CN CN98810785A patent/CN1278266A/zh active Pending
- 1998-10-29 SK SK634-2000A patent/SK6342000A3/sk unknown
- 1998-10-29 KR KR1020007004641A patent/KR20010031591A/ko not_active Application Discontinuation
- 1998-10-29 AT AT98956314T patent/ATE239750T1/de not_active IP Right Cessation
- 1998-10-29 ES ES98956314T patent/ES2198766T3/es not_active Expired - Lifetime
- 1998-10-29 CA CA002307828A patent/CA2307828A1/en not_active Abandoned
- 1998-10-29 EP EP98956314A patent/EP1027361B1/de not_active Expired - Lifetime
- 1998-10-29 DK DK98956314T patent/DK1027361T3/da active
- 1998-10-29 PT PT98956314T patent/PT1027361E/pt unknown
- 1998-10-29 HU HU0004323A patent/HUP0004323A2/hu unknown
- 1998-10-29 IL IL13499698A patent/IL134996A0/xx unknown
- 1998-10-29 BR BR9813317-9A patent/BR9813317A/pt not_active IP Right Cessation
- 1998-10-29 TR TR2000/01140T patent/TR200001140T2/xx unknown
- 1998-10-29 AU AU12867/99A patent/AU1286799A/en not_active Abandoned
- 1998-11-30 TW TW087117981A patent/TW486485B/zh active
-
2000
- 2000-04-25 NO NO20002099A patent/NO20002099L/no not_active Application Discontinuation
- 2000-05-11 BG BG104425A patent/BG104425A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0004323A2 (hu) | 2001-02-28 |
BR9813317A (pt) | 2000-08-22 |
JP2001521038A (ja) | 2001-11-06 |
CN1278266A (zh) | 2000-12-27 |
AR015986A1 (es) | 2001-05-30 |
DE69814441T2 (de) | 2004-04-08 |
WO1999021864A1 (en) | 1999-05-06 |
TR200001140T2 (tr) | 2001-05-21 |
CO4990972A1 (es) | 2000-12-26 |
CA2307828A1 (en) | 1999-05-06 |
TW486485B (en) | 2002-05-11 |
SK6342000A3 (en) | 2000-09-12 |
AU1286799A (en) | 1999-05-17 |
BG104425A (bg) | 2001-01-31 |
PL340253A1 (en) | 2001-01-29 |
PT1027361E (pt) | 2003-09-30 |
NO20002099L (no) | 2000-06-29 |
KR20010031591A (ko) | 2001-04-16 |
ES2198766T3 (es) | 2004-02-01 |
DK1027361T3 (da) | 2003-08-25 |
IL134996A0 (en) | 2001-05-20 |
NO20002099D0 (no) | 2000-04-25 |
DE69814441D1 (de) | 2003-06-12 |
EP1027361A1 (de) | 2000-08-16 |
EP1027361B1 (de) | 2003-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE435861T1 (de) | 12,13-cyclopropan-epothilonderivate | |
IS4970A (is) | Setnar 6,6-heteró-bísýklískar afleiður | |
DE69736711D1 (de) | Substituierte 6,5-heterobicyclische-derivate | |
NO2006016I1 (no) | 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat | |
PT993456E (pt) | 4,5-diaril-imidazoles 2-substituidos | |
DK1000048T3 (da) | Substituerede 1,2,3,4-tetrahydronapthalenderivater | |
ATE310742T1 (de) | C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE | |
ATE275151T1 (de) | 3,6-ketal-makrolidantibiotika | |
ATE377018T1 (de) | Erythromycinderivate | |
NO993876D0 (no) | 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater | |
DE69821009D1 (de) | 6,9-verbrückte erythromycin-derivate | |
ATE231847T1 (de) | Substituierte 1,2,3,4- tetrahydronaphthalinderivate | |
ATE239750T1 (de) | 6,11-verbrückte erythromycinderivate | |
ID21413A (id) | Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on | |
TR199800988A3 (tr) | 5' Deoksi-Sitidin türevleri. | |
EE200000447A (et) | 1,3,4-oksadiasolooni derivaadid | |
LV11898A (lv) | Eritromicina atvasinajumi | |
DK1149106T3 (da) | 4,5-azolo-oxindoler | |
DK1068200T3 (da) | 2,4,4-trisubstituerede-1,3-dioxolanfungicider | |
ID24047A (id) | Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on | |
DE69722064D1 (de) | 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate | |
PT984975E (pt) | Derivados de eritromicina multiciclicos | |
BR1100453A (pt) | derivados de eritromicina | |
ZA989848B (en) | 6,11-bridged erythromycin derivatives | |
SI1015467T1 (en) | 6,9-bridged erythromycin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1027361 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |